1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Benefits and challenges of next generation sequencing in routine assessment of myeloid neoplasms: MSKCC two-year experience
    Meeting Abstract

    Middha, S.; Zaidinski, M.; Son, J.; Mohanty, A.; Zehir, A.; Cheng, D.; Nafa, K.; Benayed, R.; Jour, G.; Tian, S.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Validation and clinical implementation of next-generation sequencing for routine IGH and TCRG clonality assessment
    Meeting Abstract

    Arcila, M. E.; Baldi, T.; Syed, M.; Rijo, I.; Bakas, J.; Momin, Z.; Ladanyi, M.; Nafa, K.
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Clinical monitoring of patients with myeloid malignancies using targeted next-generation sequencing
    Meeting Abstract

    Mohanty, A.; Zaidinski, M.; Son, J.; Zehir, A.; Middha, S.; Cheng, D. T.; Jour, G.; Tian, S. K.; DeLair, D.; Sadri, N.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Targeted sequencing analysis of commonly mutated genes in chronic myelomonocytic leukemia using NGS: Impact and clinical implications
    Meeting Abstract

    Valencia, A.; Abdel-Wahab, O.; Buchi, F.; Masala, E.; Sanna, A.; Gozzini, A.; Figueroa, M. E.; Contini, E.; Torricelli, F.; Allione, B.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • Identification of efficacy biomarkers in a large metastatic renal cell carcinoma (mRCC) cohort through next-generation sequencing (NGS): Results from RECORD-3
    Meeting Abstract

    Hsieh, J. J.; Chen, D.; Wang, P. I.; Chen, Y. B.; Redzematovic, A.; Marker, M.; Patel, P.; Chevinsky, M.; Bhanot, U.; Pinciroli, P.; more...
    BJU International (2015)

    Fulltext@MSK | Save
  • Probing the transcription cycle in real-time with 3D superresolution interferometry
    Meeting Abstract

    Wang, G.; Hauver, J.; Thomas, Z.; Darst, S. A.; Pertsinidis, A.
    Biophysical Journal (2015)

    Fulltext@MSK | Save
  • Efficacy and safety in key patient subgroups of vivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naive patients with advanced melanoma (MEL) (Checkmate 067)
    Meeting Abstract

    Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Wagstaff, J.; Hogg, D.; Hill, A.; Carlino, M. S.; more...
    Asia-Pacific Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Clinical response, progression-free survival (PFS) and safety in patients (pts) with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI) versus IPI monotherapy in Checkmate 069 study
    Meeting Abstract

    Hodi, F. S.; Postow, M. A.; Chesney, J.; Pavlik, A. C.; Robert, C.; Grossman, K.; McDermott, D.; Linette, G.; Meyer, N.; Giguere, J. K.; more...
    Asia-Pacific Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • CheckMate 067: A phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with ipilimumab (IPI) versus IPI monotherapy in previously untreated patients (pts) with advanced melanoma (MEL)
    Meeting Abstract

    Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; more...
    Annals of Oncology (2015)

    Fulltext@MSK | Save
  • Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity
    Journal Article

    Paterson, A. M.; Lovitch, S. B.; Sage, P. T.; Juneja, V. R.; Lee, Y.; Trombley, J. D.; Arancibia-Carcamo, C. V.; Sobel, R. A.; Rudensky, A. Y.; Kuchroo, V. K.; more...
    Journal of Experimental Medicine (2015)

    Fulltext@MSK | Save